Skip to content
Toggle Navigation
Technology
VSE Technology
Integrating VSEs
Ways of Working
Product
CellVantage™-AAV
CellVantage™-LV
CellVantage™-Vaccines
Virica Advantage
Our Offering
Our Toolbox
Additional Services
Regulatory Support
Integrating VSEs
News and Events
Insights
Latest News
Events
Resources
Resources
Brochure
Infographic
Poster
Whitepaper
Article
Video
View All
Category
Cell & Gene Therapies
Vaccines
October 2nd, 2025
Poster
Cell & Gene Therapies
Enhancing Lentiviral Transduction Efficiency and Reducing MOI in Therapeutically Relevant Cell Types Using Small Molecule Viral Sensitizers
October 2nd, 2025
Poster
Cell & Gene Therapies
Optimizing AAV Production Efficiency: A Scalable Approach Using Small Molecule Viral Sensitizers
About Us
Our Story
Collaborations
Careers
Contact
Resources
Filtered (5)
Filters
Reset all
×
Article
×
5
portfolio found
Asset Type
Brochure
Poster
Whitepaper
Infographic
Article
Video
Category
Vaccines
Cell & Gene Therapies
Show
(
5
)
Cancel
Optimization of Zika Vaccine Production Using Small-Molecule Viral Sensitizers to Enhance Yields
July 17th, 2025
Article
Vaccines
Small Gains, Big Wins: How Incremental Yield Increases Drive Major Cost-Savings in Cell and Gene Therapy Manufacturing
April 20th, 2025
Article
Cell & Gene Therapies
Harnessing the Statistical Power of Design of Experiments to Maximize Viral Vector Biomanufacturing Production
April 20th, 2025
Article
Cell & Gene Therapies
Overcoming the Challenges of Antiviral Defenses in Viral Vector Manufacturing
April 20th, 2025
Article
Cell & Gene Therapies
Pfizer Paper – Production of rAAV by plasmid transfection induces Antiviral inflammatory responses in suspension HEK293 cells
April 20th, 2025
Article
Cell & Gene Therapies
Page load link
Go to Top
